ABOUT THE PRODUCT
Tegoprubart is an anti-CD40L antibody in clinical development for the prevention of organ transplant rejection. It is being evaluated in Phase 2 and Phase 1b clinical trials.
Information is owner-confirmed
Last updated 5 months ago
Price range